Dr Reddy's Laboratories Receivables 2010-2024 | RDY

Dr Reddy's Laboratories receivables for the quarter ending December 31, 2024 were $1.078B, a 14.32% increase year-over-year.

  • Dr Reddy's Laboratories receivables for 2024 were $0.963B, a 9.18% increase from 2023.
  • Dr Reddy's Laboratories receivables for 2023 were $0.882B, a 0.23% increase from 2022.
  • Dr Reddy's Laboratories receivables for 2022 were $0.88B, a 29.6% increase from 2021.

Dr Reddy's Laboratories Receivables 2010-2024 | RDY

  • Dr Reddy's Laboratories receivables for 2024 were $0.963B, a 9.18% increase from 2023.
  • Dr Reddy's Laboratories receivables for 2023 were $0.882B, a 0.23% increase from 2022.
  • Dr Reddy's Laboratories receivables for 2022 were $0.88B, a 29.6% increase from 2021.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
BridgeBio Pharma (BBIO)$6.9B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M